Retinoid action is mediated through the retinoid receptor proteins RAR and RXR, which modulate gene expression directly, by binding RA-responsive elements (RAREs) and, indirectly, by inhibiting the activity of other transcription factor complexes such as AP-1 [1] . RXR also functions by heterodimerization with other members of the steroid hormone receptor superfamily, such as the thyroid hormone receptor, peroxisome proliferator activator receptor (PPAR) and the vitamin D receptor [9] . Many of the downstream pathways that mediate retinoid-induced changes in cells have yet to be defined. Increased cell-cell adhesion and the recruitment of cytoplasmic β-catenin to the membrane accompany the effects of 9-cis-RA (9cRA) on epithelial differentiation [2, 3] . In contrast, elevated cytoplasmic β-catenin levels are associated with Wnt signaling, LEF/TCF-mediated transactivation and oncogenesis [6, [10] [11] [12] [13] . To investigate this potential connection, we first tested the ability of 9cRA to influence β-catenin signaling activity by measuring β-catenin-LEF/TCF-regulated luciferase reporter activity. We used 9cRA in these experiments because it can activate RXR homodimers in addition to RAR-RXR heterodimers. Figure 1a shows that, in MCF-7 breast cancer cells, which express wildtype adenomatous polyposis coli (APC), 9cRA reduced LEF/TCF reporter activity in a dose-dependent manner. Similar results were obtained with two other cell lines that are growth inhibited by RA (HS578t and SKBR3 cells; data not shown).
The β-catenin protein and signaling activity is controlled by APC-regulated serine phosphorylation and ubiquitindependent protein degradation [5, 14] . We next tested whether the actions of RA on β-catenin-LEF/TCF signaling required APC, and β-catenin ubiquitination. Figure 1b shows that RA effectively inhibited LEF/TCF reporter activity in retinoid-sensitive APC-mutant colon cancer cells (Caco-2) and demonstrates that APC is not required for RA to inhibit β-catenin-LEF/TCF signaling. Similar results were obtained in another retinoid-sensitive APCmutant cell line HT29 (data not shown). If the actions of RA involve the targeting of cytoplasmic β-catenin for ubiquitination and proteosomal degradation (in an APC-independent manner), one would anticipate that the signaling activity of stable, non-ubiquitinatable mutants of β-catenin would not be affected by RA. For example, the signaling activity of a β-catenin mutant in which the Ser37 residue is mutated to Ala (S37A) is resistant to inhibition by APC [14] . In contrast, Figure 1c shows that RA effectively inhibited LEF/TCF reporter activity induced by the S37A stable mutant form of β-catenin and further indicates that the effects of RA are unrelated to events that regulate β-catenin ubiquitination and proteosomal degradation [15] .
Consistent with this, the cytoplasmic pool of β-catenin was unaffected by RA in Caco-2 cells (Figure 1d ). These results show that, unlike APC and cadherins, the influence of RA on β-catenin signaling does not require a change in the signaling pool of β-catenin itself.
To investigate the receptor specificity of vitamin A action on β-catenin-LEF/TCF signaling, we tested the role of PPAR and vitamin D receptors, two other steroid receptor families that are known to influence colon cancer [16] . Caco-2 cells were used in these experiments because they express PPAR, vitamin D and retinoid receptors, and respond to all of the cognate ligands [16] [17] [18] . Figure 2a shows that treatment of Caco-2 cells with three different PPAR ligands did not modulate β-catenin signaling activity. Vitamin D3 treatment exerted a small but consistent inhibitory effect on β-catenin signaling activity. In contrast, 9cRA ( Figure 1 ) and all-trans-RA markedly decreased LEF reporter activity. Taken together, these data point to a direct effect of RA on the regulation of β-catenin-LEF/TCF-mediated transactivation, potentially mediated by RAR and/or RXR.
To test whether β-catenin could interact directly with retinoid receptors, glutathione-S-transferase (GST) 'pulldown' experiments were carried out. Figure 2b shows that, compared with GST alone, in vitro transcribed and translated RAR and RXR interacted slightly with a GST-β-catenin fusion protein. Importantly, the interaction of β-catenin with RAR, but not with RXR, was markedly increased by RA. The presence of RXR in the reaction did not inhibit or stimulate β-catenin-RAR interactions (data not shown). These data suggest that, for RA to regulate β-catenin-LEF/TCF reporter activity, it might modulate assembly of the β-catenin-LEF/TCF complex. To test this, we investigated the effects of RA and RAR on TCF4-β-catenin interactions. Figure 2c shows that, in the presence of RA, RAR did indeed reduce GST-β-catenin-TCF interactions. Significant inhibition of TCF4 binding was evident even in the presence of approximately equimolar amounts of RAR. These results indicate that RA-activated RAR competes with TCF for binding to β-catenin in a reaction that does not require RAR heterodimerization with RXR.
A direct interaction between β-catenin and RAR together with the ability of β-catenin to act as a co-activator for LEF/TCF suggests that β-catenin might regulate the activity of RAR-responsive promoters. We next tested the ability of β-catenin to augment the RA stimulation of RA-responsive promoters. Figure 3a shows that transient transfection of the S37A stable form of β-catenin into MCF-7 cells increased the activity of the RA-responsive RARβ promoter. Similar results were obtained using another RARE reporter but not with an estrogen-responsive reporter construct (Figure 3b,c) . Like some other co-activators, β-catenin slightly activated RARE reporters in the absence of RA but this was always 10% or less of RA-stimulated values (data not shown). IκBα, the inhibitor of the transcription factor NFκB, can also interact with retinoid receptors, in this case with RXR, not RAR [19] . In contrast to β-catenin, however, IκBα inhibits RXRE reporter activity. Perhaps the documented ability of the β-catenin carboxyl terminus to recruit the transcriptional machinery allows RAR-β-catenin heterodimers to transactivate [20] . Retinoids are important signaling molecules, both in the adult and in the developing embryo, and RA can dramatically inhibit the development of anterior structures [21] . Wnt and its Drosophila homologue Wingless are also important in embryonic patterning, and overexpression of Wnt-1 or β-catenin in Xenopus results in anterior axis duplication [7, 8, 22] . Our demonstration that RA influences β-catenin-LEF/TCF signaling and that β-catenin influences RA signaling suggests that these two important developmental pathways might interact more directly than previously envisioned. Because increased levels of cytoplasmic β-catenin and/or increased β-catenin-LEF/TCFsignaling can transform cells, we propose that one mechanism whereby RA inhibits tumorigenesis might be by directly affecting β-catenin-LEF/TCF transactivation. If this is true, RA could be considered as a therapeutic agent for cancers in which β-catenin-LEF/TCF transactivation is overactive. In other studies, we showed that RA treatment of some breast cancer cells increases cadherin expression and function [2] . Increased cadherin expression Brief Communication 1417 Figure 2 (a) Effect of various steroid-receptor-specific ligands on β-catenin-LEF signaling. Caco-2 cells were transiently transfected with the LEF/TCF reporters and treated with the indicated ligands (10 -6 M) for 48 h. Three different PPAR ligands, BRL49653, PGJ2 and NS398, did not affect LEF/TCF reporter activity. Vitamin D3 exerted a small but consistent inhibitory affect. All-trans-RA (ATRA) markedly inhibited reporter activity. Reporter activity was measured as described in the Supplementary material. DMSO, dimethyl sulphoxide. (b) Interaction of β-catenin with RAR and RXR. In vitro transcribed and translated 35 S-labeled RARα and RXRα were incubated, in the absence (-) or presence (+) of 9cRA (10 -6 M), with glutathione-agarose prebound with GST or GST-β-catenin for 30 min at 25°C. After washing, the protein interacting with β-catenin was eluted by adding 15 mM reduced glutathione, resolved on 12% gels by SDS-PAGE and detected using autoradiography. (c) RARα competes with TCF4 for binding to GST-β-catenin. Two TCF4 products were consistently observed after the transcription and translation reaction. The β-catenin-binding site of TCF is at the amino terminus [20] . Because both forms of TCF4 readily bound β-catenin, it is probable that the smaller species represents either a proteolytic product that is missing part of the carboxyl terminus, or usage of an alternative can also modulate β-catenin signaling, by depleting the cytoplasmic pool of β-catenin [23, 24] . Depending on the cellular context, therefore, RA can increase the adhesive function of β-catenin and independently decrease its signaling activity. Taken together with the effects of RA on other known pathways, we suggest that the pleiotropic and context-dependent effects of RA result from the differential regulation of AP-1, RARE and β-catenin-LEF/TCFactivated transcriptional programs (Figure 4 ).
Supplementary material
Supplementary material including additional methodological detail is available at http://current-biology.com/supmat/supmatin.htm.
Figure 4
Three pathways affected by RA. The ability of RA to influence AP-1 and β-catenin-LEF/TCF signaling depends on RAR but not RXR, whereas the ability of RA to influence RARE activation requires RAR-RXR heterodimer formation. The output phenotype then depends on the genetic program that is activated by the combined effects of AP-1 and/or β-catenin-LEF/TCF inhibition and RARE activation. The contribution from each pathway will vary depending on the levels of the reactants. In colon cancer cells, which have very high levels of β-catenin, RA-activated RAR might preferentially affect this pathway. 
Supplementary materials and methods

Transfections and reporter assays
To investigate β-catenin-LEF/TCF signaling, cells were transiently transfected as described previously with the LEF/TCF reporters, TOPFlash (optimal LEF-binding site) and FOPFlash (mutated LEF-binding sites) [S1,S2] . Data were normalized for transfection efficiency, using pCMVRenilla Luciferase and the Dual Luciferase Assay System (Promega). To investigate RARE and ERE reporter activity, MCF-7 cells were grown in medium containing 5% charcoal-stripped serum for 36 h (and phenolred-free medium for estrogen experiments), and the medium replaced every 6 h. The following RARE reporter plasmids were used: a fragment of the RARβ promoter containing the DR5 retinoid-response element (RAREβ-TK-Luc; [S3] ); p∆MMTV-TREpal-Luc, in which the GRE element was removed from the MMTV promoter and replaced with TREpal and TREpal-TK-Luc [S4] . The estrogen-responsive promoter, pGLB-mERE, consists of an ERE in place of the GRE in the MMTV promoter [S5] . Cells were transiently transfected with a RARE-regulated or ERE-regulated reporter, or control plasmids (TK-Luc; ∆MMTV-Luc; pGLB-mNON), along with either empty vector or the stable S37A form of β-catenin using the calcium phosphate method. Following transfections, cells were maintained in medium containing charcoal-stripped serum and treated with 10 -6 M 9-cis-RA or 10 -9 M estrogen or ethanol for 48 h. Reporter activity was quantified using the Dual Luciferase Assay System.
Cell fractionation and western blotting
Caco-2 cells were first lysed in hypotonic lysis buffer and ultracentrifuged at 100,000 × g for 1 h (cytoplasmic extract) [S6] . The pellet was extracted in NP-40 lysis buffer (NP-40 soluble). For whole cell lysates (WCL), cells were directly solublized in SDS sample buffer. Nuclear extracts were prepared according to established protocols [S7] . Equal protein was resolved on SDS-PAGE and analyzed by immunoblot using an anti-β-catenin antibody (Transduction Labs), as described earlier [S6] .
GST pull-down assays
Purified GST or GST-β-catenin (7 nmol) was absorbed onto glutathione-agarose in 1.25 ml binding buffer (20 mM Hepes-KOH pH 7.4, 50 mM potassium chloride, 1 mM magnesium chloride, 0.1 mg/ml bovine serum albumin) containing 62.5 µl of a 50% slurry of glutathione-agarose. The agarose beads were washed three times and resuspended in 250 µl binding buffer. For assay, 20 µl GST-β-cateninbound agarose was diluted in 270 µl binding buffer, and then mixed with 10 µl wheat germ extract containing 35 S-labeled translation product (RAR, RXR or TCF4) for 30 min at 25°C by gentle shaking. After centrifugation, the supernatant was removed and the beads were washed once with binding buffer, following which 50 µl 50 mM TrisHCl (pH 8.0) containing 15 mM reduced glutathione was added to the wet agarose beads, the mixture was shaken gently for 1 h at 25°C, and 40 µl of the supernatant was recovered after centrifugation; 20 µl of the supernatant was resolved by SDS-PAGE on 12% gels and detected by autoradiography.
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